Enanta Pharmaceuticals (ENTA) Cash & Current Investments (2012 - 2026)
Enanta Pharmaceuticals (ENTA) recorded Cash & Current Investments of $189.51 million in fiscal Q3 2026 (quarter ended Jun 30, 2026), down 7.2% from $204.11 million a year earlier but up 15.7% from the prior quarter.
Powered by 
Analysis
Enanta Pharmaceuticals (ENTA) Cash & Current Investments (2012 - 2026) Analysis & Trends
At the end of FY2025 (ended Sep 30, 2025), Enanta Pharmaceuticals reported Cash & Current Investments of $188.86 million, down 23.9% from FY2024.
- Annual Cash & Current Investments has a five-year compound annual growth rate of -13.4% (FY2020 to FY2025).
- Across earlier fiscal years, Cash & Current Investments came in at $248.19 million in FY2024 (-32.9%), $369.91 million in FY2023 (+48.4%), $249.23 million in FY2022 (+2.1%) and $244 million in FY2021 (-36.9%).
- Quarterly Cash & Current Investments has ranged from $163.77 million in fiscal Q2 2026 to $386.59 million in fiscal Q3 2023 over the past five years.
- On a year-over-year basis, Cash & Current Investments has declined for nine consecutive quarters, with an average decline of 22.0% over the last eight quarters.
- Peak year-over-year performance for Cash & Current Investments in the last five years was growth of 57.2% in fiscal Q1 2024, against a decline of 40.5% in fiscal Q3 2024 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $163.77 million (Q2 2026), $185.85 million (Q1 2026) and $188.86 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.76 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 9.92 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.97 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Enanta Pharmaceuticals | 377.40 Mn | -350.60 Mn | - | 189.51 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 189.51 Mn |
| Mar 31, 2026 | 163.77 Mn |
| Dec 31, 2025 | 185.85 Mn |
| Sep 30, 2025 | 188.86 Mn |
| Jun 30, 2025 | 204.11 Mn |
| Mar 31, 2025 | 193.38 Mn |
| Dec 31, 2024 | 216.69 Mn |
| Sep 30, 2024 | 248.19 Mn |
| Jun 30, 2024 | 230.09 Mn |
| Mar 31, 2024 | 300.31 Mn |
| Dec 31, 2023 | 337.15 Mn |
| Sep 30, 2023 | 369.91 Mn |
| Jun 30, 2023 | 386.59 Mn |
| Mar 31, 2023 | 210.08 Mn |
| Dec 31, 2022 | 214.47 Mn |
| Sep 30, 2022 | 249.23 Mn |
| Jun 30, 2022 | 253.29 Mn |
| Mar 31, 2022 | 280.33 Mn |
| Dec 31, 2021 | 259.05 Mn |
| Sep 30, 2021 | 244.00 Mn |
API Access
Enanta Pharmaceuticals Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=ENTA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "ENTA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=ENTA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();